In Beijing, One Center EC Review is Sufficient for Multicenter Study

A “Beijing Medical Ethics Committee (EC) Review Mutual Recognition Alliance” was formed on December 1, 2020. The mutual recognition alliance, currently constitutes 15 member institutes, will greatly accelerate and simplify the clinical study process, especially for the multicenter clinical studies.

Email info@inspirativemed.com to get the full list of the 15 institutes.

In China, all the clinical studies should be reviewed by the ethic committee in the relevant hospital or institutions. As for multicenter clinical studies in China, a same study will be reviewed by multiple ECs and this repetitive review process may arise various problems, such as long waiting time, different application forms, different requirements, different examination standards, etc. In this case, the clinical process will be prolonged as well. The clinical trials are expedited after establishment of the recognition alliance.

Takeaways of the Ethics Review Mutual Recognition

• Members of the Alliance will follow unified working rules
• Members of the Alliance will recognize the ethicalreview following an agreed review frequency and time
• Avoiding repeated ethical reviews
• Saving time for manufacturers and investigators